On Friday, the European Commission (EC) approved Bristol Myers Squibb & Co’s (NYSE:BMY) Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with unresectable or ...
The recent cavalcade of biotech deals continued Friday morning, when Bristol Myers Squibb said it had agreed to pay $1.5 billion to acquire Orbital Therapeutics, an early-stage, privately held biotech ...
In the UK today, The Wave announced it was closing, indefinitely. The Bristol-based wave pool shut suddenly, cancelled bookings and most of its website was inoperable. “I’ve been working with them for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback